However, IHC showed more positive staining in primary melanoma than in nevi, implying that IHC could be used for monitoring SPP1 expression to differentiate nevi from melanoma while ELISA could be more appropriate to distinguish primary from metastatic melanoma. This evidence concerns the gene SPP1 and metastatic melanoma.